Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Classification of Acute Myeloid Leukemia and Myelodysplastic Syndrome Based on Molecular Profiling

Sally Agersborg, MDPhD, Maya Thangavelu, PhD, Wanlong Ma, BS, Steven Brodie, PhD, Christopher Mixon, MD, Wayne Chen, MD, Maher Albitar

Blood (2015) 126 (23): 3836.

https://doi.org/10.1182/blood.V126.23.3836.3836

Published: 2015

Journal Articles

The Role of Molecular Profiling of Bone Marrow Samples in Confirming the Diagnosis of Myelodysplastic Syndrome in Patients Presenting with Cytopenia

Maya Thangavelu, PhD, Wanlong Ma, BS, Steven Brodie, PhD, Christopher Mixon, MD, Wayne Chen, MD, Sally Agersborg, MDPhD, Maher Albitar

Blood (2015) 126 (23): 1667.

https://doi.org/10.1182/blood.V126.23.1667.1667

Published: 2015

Journal Articles

Interclonal and Intraclonal Heterogeneity in Patients with Early Myelodysplastic Syndrome (MDS)

Maya Thangavelu, PhD, Wanlong Ma, BS, Steven Brodie, PhD, Christopher Mixon, MD, Wayne Chen, MD, Sally Agersborg, MDPhD, Maher Albitar, MD

Blood (2015) 126 (23): 1670.

https://doi.org/10.1182/blood.V126.23.1670.1670

Published: 2015

Journal Articles

Complete Molecular Risk Stratification of De Novo Acute Myeloid Leukemia with Intermediate Cytogenetics Using an Eight-Gene Panel

Maya Thangavelu, PhD, Ryan Olson, MD, Li Li, MD, Wanlong Ma, MS, Steve Brodie, PhD, Chris Mixon, MD, Sally Agersborg, MDPhD, Eric Wei, MD PhD, Maher Albitar, MD

Blood (2014) 124 (21): 2333.

https://doi.org/10.1182/blood.V124.21.2333.2333

Published: 2014

Journal Articles

Deep Sequencing of Peripheral Blood Plasma DNA As a Reliable Test for Confirming the Diagnosis of Myelodysplastic Syndrome

Ferras Albitar, BS, Wanlong Ma, MS, Kevin Diep, BS, Ivan De Dios, Sally Agersborg, MDPhD, Maya Thangavelu, PhD, Steve Brodie, PhD, Maher Albitar, MD

Blood (2014) 124 (21): 1909.

https://doi.org/10.1182/blood.V124.21.1909.1909

Published: 2014

Journal Articles

Molecular Profiling in Confirming the Diagnosis of Early Myelodysplastic Syndrome

Maya Thangavelu, PhD, Ryan Olson, MD, Li Li, MD, Wanlong Ma, MS, Steve Brodie, PhD, Chris Mixon, MD, Sally Agersborg, MDPhD, Eric Wei, MD PhD, Maher Albitar, MD

Blood (2014) 124 (21): 4639.

https://doi.org/10.1182/blood.V124.21.4639.4639

Published: 2014

Journal Articles

Determining Tumor Load and Biallelic Mutation in Patients with CALR Mutation Using Peripheral Blood Plasma

Kevin Diep, BS, Wanlong Ma, MS, Ferras Albitar, BS, Ivan De Dios, Sally Agersborg, MDPhD, Maya Thangavelu, PhD, Steve Brodie, PhD, Maher Albitar, MD

Blood (2014) 124 (21): 1818.

https://doi.org/10.1182/blood.V124.21.1818.1818

Published: 2014

NARROW

Classification of Acute Myeloid Leukemia and Myelodysplastic Syndrome Based on Molecular Profiling

The Role of Molecular Profiling of Bone Marrow Samples in Confirming the Diagnosis of Myelodysplastic Syndrome in Patients Presenting with Cytopenia

Interclonal and Intraclonal Heterogeneity in Patients with Early Myelodysplastic Syndrome (MDS)

Complete Molecular Risk Stratification of De Novo Acute Myeloid Leukemia with Intermediate Cytogenetics Using an Eight-Gene Panel

Deep Sequencing of Peripheral Blood Plasma DNA As a Reliable Test for Confirming the Diagnosis of Myelodysplastic Syndrome

Molecular Profiling in Confirming the Diagnosis of Early Myelodysplastic Syndrome

Determining Tumor Load and Biallelic Mutation in Patients with CALR Mutation Using Peripheral Blood Plasma

Email alerts

ASH Publications

American Society of Hematology

Classification of Acute Myeloid Leukemia and Myelodysplastic Syndrome Based on Molecular Profiling

The Role of Molecular Profiling of Bone Marrow Samples in Confirming the Diagnosis of Myelodysplastic Syndrome in Patients Presenting with Cytopenia

Interclonal and Intraclonal Heterogeneity in Patients with Early Myelodysplastic Syndrome (MDS)

Complete Molecular Risk Stratification of De Novo Acute Myeloid Leukemia with Intermediate Cytogenetics Using an Eight-Gene Panel

Deep Sequencing of Peripheral Blood Plasma DNA As a Reliable Test for Confirming the Diagnosis of Myelodysplastic Syndrome

Molecular Profiling in Confirming the Diagnosis of Early Myelodysplastic Syndrome

Determining Tumor Load and Biallelic Mutation in Patients with CALR Mutation Using Peripheral Blood Plasma

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only